22.02.2026, 1009 Zeichen

Agrana: Due to the continuing difficult market environment in the Sugar segment, a non-cash impairment loss is expected to be recognised in the Agrana Group as part of the indication-based impairment test of assets as of the balance sheet date. The impairment is forecast to impact the assets of the ACS – Sugar segment to an extent of between € 45 and € 55 million. The final amount of the impairment loss will be determined in the course of preparing AGRANA's consolidated financial statements for the 2025|26 financial year (balance sheet date: 28 February 2026). The forecast non-cash impairment will be reported under exceptional items and thus have a negative impact on the previous guidance for EBIT^1. At Group level, management had expected EBIT to increase significantly to a range of around € 45 million to € 60 million for the 2025|26 financial year prior to the impairment.
Agrana: weekly performance: -1.71%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (17/02/2026)

Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #1126: Spannung zum Q1-Finale, Christian Stocker zur Bodenbildung, cyan und Reploid überzeugen und die +50-Sache

Bildnachweis

Aktien auf dem Radar:CA Immo, UBM, Semperit, Austriacard Holdings AG, EuroTeleSites AG, Flughafen Wien, Marinomed Biotech, voestalpine, Wienerberger, Zumtobel, Kapsch TrafficCom, Andritz, AT&S, DO&CO, Strabag, RBI, Agrana, FACC, CPI Europe AG, Bajaj Mobility AG, Verbund, Wolford, Oberbank AG Stamm, RHI Magnesita, Amag, EVN, Österreichische Post, Telekom Austria, Infineon, BASF, Symrise.

---